Company
Bristol Myers Squibb Company
430 East 29th Street
New York,
NY 10016
United States
Ratios
Stock Price Chart
Annual Returns
Financial Statements
52-Week High/Low
Annual Earnings
Earnings Calendar
Dividend History
Recently Viewed
| Symbol | Price |
|---|
Bristol Myers Squibb Company ( BMY)
Company > Health Care > Major Pharmaceuticals
LAST CLOSE
$ 60.75 (+ 0.59)
TRADING VOLUME
13,598,200
MARKET CAP
$ 98.2B
52-WEEK HIGH/LOW
$ 46.4 - $66.74
PREVIOUS ESTIMATE
2020 2021
$ 0 | -
P/E RATIO P/E RATIO
Trailing Forward
0 | -
P/E RATIO P/E RATIO
Trailing Forward
- | -
P/E RATIO P/E RATIO
Trailing Forward
- | -
BMY
S&P 500
30-DAY CHANGE
-3.01%
-0.41%
90-DAY CHANGE
-2.77%
3.86%
180-DAY CHANGE
0.36%
12.11%
52-WEEK CHANGE
-0.55%
29.26%
DIVIDEND
0.45
DIVIDEND YIELD
0.75%
OUTSTANDING
1,632,198,774
50-DAY AVG VOLUME
9148930.26
FISCAL YEAR END
Dec 31
Last Earning Date
Feb 04, 2021
EX-DIVIDEND DATE
Jan 02, 2020
EX-DIVIDEND DATE
Jan 02, 2020
Ratios
BOOK VALUE $8.63
DEBT TO EQUITY 0.4
RETURN ON EQUITY 34.83%
Stock Price Chart +
Quarterly Returns +
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | -12.7 | -8.3 | 3.9 | -6.3 | -6.6 | 9.3 | -2.3 | 27.8 | -3.3 | - |
| Q2 | - | 5.5 | -3.2 | -10.2 | 3.2 | 15.8 | 3.8 | -6 | 9.5 | 7.1 | - |
| Q3 | - | 2.7 | 10.7 | 13.3 | 15.2 | -26.7 | -10 | 6.3 | 4.1 | -5.5 | - |
| Q4 | - | 1.9 | 25.1 | -15.8 | -4.5 | 9.1 | 16.8 | 16.9 | 16.5 | -2.9 | - |
Monthly Returns +
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2020 | -1.12 | -8.45 | -3.58 | 9.1 | -1.79 | -1.54 | -0.24 | 6.03 | -2.89 | -3.98 | 7.59 | -1.35 |
Annual Returns +
| Year | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | 17% | -26% | -52% | 29% | -7% | -6% | 20% | 5% | -6% | 15% |
| Year | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Returns | 9% | 39% | -4% | 70% | 14% | 19% | -13% | 8% | -13% | 24% | -4% | -2% |
Financial Statements
Income Statement
| Millions of US $ except per share data | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|
| Revenue | 42518 | 26145 | 22561 |
| Cost Of Goods Sold | 11773 | 8078 | 6547 |
| Gross Profit | 30745 | 18067 | 16014 |
Balance Sheet
| Millions of US $ except per share data | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|
| Cash On Hand | 15831 | - | 8884 |
| Notes And Loans Receivable | - | - | - |
| Inventory | 2074 | - | 1195 |
Cash Flow Statement
| Millions of US $ except per share data | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|
| Net Income/Loss | -8995 | - | 4947 |
| Total Depreciation And Amortization - Cash Flow | 10380 | - | 637 |
| Other Non-Cash Items | 11684 | - | 224 |
Income Statement
| Millions of US $ except per share data | 2020-12-31 | 2020-09-30 | 2020-06-30 |
|---|---|---|---|
| Revenue | 11068 | 10540 | 10129 |
| Cost Of Goods Sold | 2910 | 2502 | 2699 |
| Gross Profit | 8158 | 8038 | 7430 |
| Research And Development Expenses | 3750 | 2499 | 2522 |
| SG&A Expenses | 2721 | 1706 | 1628 |
| Other Operating Income Or Expenses | -9612 | 915 | 736 |
| Operating Expenses | 21519 | 8283 | 8502 |
| Operating Income | -10451 | 2257 | 1627 |
| Total Non-Operating Income/Expense | - | - | - |
| Pre-Tax Income | -10451 | 2257 | 1627 |
| Income Taxes | -424 | 379 | 1707 |
| Income After Taxes | -10027 | 1878 | -80 |
| Other Income | - | - | - |
| Income From Continuous Operations | -10027 | 1878 | -80 |
| Income From Discontinued Operations | - | - | - |
| Net Income | -10027 | 1872 | -85 |
| EBITDA | -7761 | 4912 | 4185 |
| EBIT | -10451 | 2257 | 1627 |
| Basic Shares Outstanding | 2258 | 2257 | 2263 |
| Shares Outstanding | 2258 | 2290 | 2263 |
| Basic EPS | -4.44 | 0.83 | -0.04 |
| EPS - Earnings Per Share | -4.43 | 0.82 | -0.04 |
Balance Sheet
| Millions of US $ except per share data | 2020-12-31 | 2020-09-30 | 2020-06-30 |
|---|---|---|---|
| Cash On Hand | 15831 | 21155 | 21658 |
| Notes And Loans Receivable | - | - | - |
| Inventory | 2074 | 1949 | 2384 |
| Other Current Assets | 3786 | 3111 | 2446 |
| Total Current Assets | 30192 | 34277 | 34343 |
| Property, Plant, And Equipment | 5886 | 5740 | 5777 |
| Long-Term Investments | 433 | 495 | 523 |
| Goodwill And Intangible Assets | 73790 | 77215 | 79749 |
| Other Long-Term Assets | 7019 | 6896 | 6596 |
| Total Long-Term Assets | 88289 | 91259 | 93733 |
| Total Assets | 118481 | 125536 | 128076 |
| Total Current Liabilities | 19080 | 20464 | 23421 |
| Long Term Debt | 48336 | 41364 | 41853 |
| Other Non-Current Liabilities | 7776 | 7565 | 7485 |
| Total Long Term Liabilities | 61519 | 54842 | 55495 |
| Total Liabilities | 80599 | 75306 | 78916 |
| Common Stock Net | 292 | 292 | 292 |
| Retained Earnings (Accumulated Deficit) | 21281 | 32414 | 31565 |
| Comprehensive Income | -1839 | -1699 | -1556 |
| Other Share Holders Equity | - | - | - |
| Share Holder Equity | 37882 | 50230 | 49160 |
| Total Liabilities And Share Holders Equity | 118481 | 125536 | 128076 |
| Receivables | 8501 | 8062 | 7855 |
| Pre-Paid Expenses | - | - | - |
52-Week High/Low
Annual Earnings
| Year | Jun | Mar | Sep | Dec | Annual |
|---|---|---|---|---|---|
| 2005 | 0.27 | 0.50 | 0.49 | 0.26 | 1.52 |
| 2006 | 0.36 | 0.34 | 0.17 | -0.06 | 0.81 |
| 2007 | 0.35 | 0.36 | 0.43 | -0.05 | 1.09 |
| 2008 | 0.33 | 0.38 | 1.28 | 0.63 | 2.62 |
| 2009 | 0.32 | 0.49 | 0.48 | 4.05 | 5.34 |
| 2010 | 0.43 | 0.53 | 0.55 | 0.28 | 1.79 |
| 2011 | 0.57 | 0.52 | 0.56 | 0.51 | 2.16 |
| 2012 | 0.64 | 0.38 | -0.43 | 0.57 | 1.16 |
| 2013 | 0.37 | 0.32 | 0.42 | 0.43 | 1.54 |
| 2014 | 0.56 | 0.20 | 0.43 | 0.01 | 1.2 |
| 2015 | 0.71 | 0.53 | 0.39 | 0.38 | 2.01 |
| 2016 | 0.74 | 0.69 | 0.77 | 0.63 | 2.83 |
| 2017 | 0.84 | 0.74 | 0.75 | 0.68 | 3.01 |
| 2018 | 0.94 | 1.01 | 1.09 | 0.94 | 3.98 |
| 2019 | 1.10 | 1.18 | 1.17 | 1.22 | 4.67 |
| 2020 | - | - | - | - | - |
Earnings Calendar
|
Quarter | Rep. Date 2020 | May 07 | Aug 06 |
Quarter | Rep. Date 2019 Mar | Apr 25 Jun | Jul 25 Sep | Oct 31 Dec | Feb 06 |
Quarter | Rep. Date 2018 Mar | Apr 26 Jun | Jul 26 Sep | Oct 25 Dec | Jan 24 |
Quarter | Rep. Date 2017 Mar | Apr 27 Jun | Jul 27 Sep | Oct 26 Dec | Feb 05 |
Quarter | Rep. Date 2016 Mar | Apr 28 Jun | Jul 28 Sep | Oct 27 Dec | Jan 26 |
Dividend History
| Year | Mar | Jun | Sep | Dec | Annual |
|---|---|---|---|---|---|
| 2020 | 0.45 | 0.45 | |||
| 2019 | 0.41 | 0.41 | 0.41 | 0.41 | 1.64 |
| 2018 | 0.4 | 0.4 | 0.4 | 0.4 | 1.6 |
| 2017 | 0.39 | 0.39 | 0.39 | 0.39 | 1.56 |
| 2016 | 0.38 | 0.38 | 0.38 | 1.14 |
Ex - Dividend Data & Date
| Year | Mar | Jun | Sep | Dec | Annual |
|---|---|---|---|---|---|
| 2020 | Jan 02 | 0.45 | 0.45 | |||
| 2019 | Jan 03 | 0.41 | Apr 04 | 0.41 | Jul 03 | 0.41 | Oct 03 | 0.41 | 1.64 |
| 2018 | Jan 04 | 0.4 | Apr 05 | 0.4 | Jul 05 | 0.4 | Oct 04 | 0.4 | 1.6 |
| 2017 | Jan 04 | 0.39 | Apr 05 | 0.39 | Jul 05 | 0.39 | Oct 05 | 0.39 | 1.56 |
| 2016 | Mar 30 | 0.38 | Jun 29 | 0.38 | Oct 05 | 0.38 | 1.14 |
